Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Mol Oral Microbiol. 2011 Jul 19;26(5):303–320. doi: 10.1111/j.2041-1014.2011.00619.x

Table 1.

Ontology analysis of calvarial bone and soft tissue pathways impacted by polymicrobial infection with P. gingivalis+T. denticola+T. forsythia1

Impacted pathway2 Impact Factor3 Input genes/no. of pathway genes4 P Value
Calvarial bone
Leukocyte transendothelial migration 55.967 49/119 0.000E0
Cell adhesion molecules 45.448 49/159 0.000E0
Adherens junction 31.999 37/77 3.510E-13
Antigen processing and presentation 17.26 37/100 5.829E-7
Phosphatidylinositol signaling system 15.717 28/75 2.497E-6
Ribosome 13.463 55/115 2.058E-5
DNA replication 12.825 26/36 3.723E-5
ECM-receptor interaction 11.145 45/81 1.755E-4
Focal adhesion 9.608 94/199 7.127E-4
B cell receptor signaling pathway 7.748 35/71 3.776E-3
Apoptosis 6.122 41/93 1.563E-2
Natural killer cell mediated cytotoxicity 5.945 47/109 1.819E-2
Cell cycle 5.81 54/124 2.041E-2
Toll-like receptor signaling pathway 5.591 48/101 2.459E-2
VEGF signaling pathway 5.518 36/76 2.616E-2
Calvarial tissue
Leukocyte transendothelial migration 79.756 14/119 0.000E0
Cell adhesion molecules 71.416 13/159 0.000E0
Adherens junction 22.027 13/77 6.282E-9
Phosphatidylinositol signaling system 14.206 7/75 1.029E-5
Ribosome 10.313 21/115 3.756E-4
PPAR signaling pathway 7.475 14/76 4.806E-3
mTOR signaling pathway 7.117 11/55 6.584E-3
Insulin signaling pathway 5.621 20/140 2.397E-2

ECM = extracellular matrix; VEGF = vascular endothelial growth factor; PPAR = peroxisome proliferator-activated receptor; mTOR = mammalian target of rapamycin.

1

The calvarial bone and tissue gene pathways were determined by Pathway Express (Draghici et al. 2007; Khatri et al. 2007).

2

Kyoto Encyclopedia of genes and genome pathways (http://www.genome.jp/kegg/).

3

The impact factor measures the pathways most affected by changes in gene expression in calvarial bone and soft tissue by considering the proportion of differentially regulated genes, the perturbation factors of all pathway genes, and the propagation of these perturbations throughout the pathway. Only pathways with an impact factor greater than 5 are included in this table.

4

Number of regulated genes in a pathway/total number of genes currently mapped to this pathway. First three pathways that are impacted both in bone and tissue are indicated in bold.